Lehrstuhl für Haut- und Geschlechtskrankheiten

Practical guidelines for the management of adverse events of the T cell engager bispecific tebentafusp (2023) Hassel JC, Berking C, Forschner A, Gebhardt C, Heinzerling L, Meier F, Ochsenreither S, et al. Journal article Adjuvant treatment and outcome of stage III melanoma patients: Results of a multicenter real-world German Dermatologic Cooperative Oncology Group (DeCOG) study (2023) Lodde GC, Hassel J, Wulfken LM, Meier F, Mohr P, Kähler K, Hauschild A, et al. Journal article XCR1 expression distinguishes human conventional dendritic cell type 1 with full effector functions from their immediate precursors (2023) Heger L, Hatscher L, Liang C, Lehmann C, Amon L, Lühr JJ, Kaszubowski T, et al. Journal article Tirbanibulin 1% Ointment Significantly Reduces the Actinic Keratosis Area and Severity Index in Patients with Actinic Keratosis: Results from a Real-World Study (2023) Kirchberger M, Gfesser M, Erdmann M, Schliep S, Berking C, Heppt M Journal article Fertilität, Kontrazeption und Teratogenität bei Immuncheckpointblockade (2023) Hassel JC, Berking C Journal article, Review article Fertilität, Teratogenität und Kontrazeption bei BRAF-/MEK-Inhibition (2023) Livingstone E, Berking C Journal article, Review article Fertility preservation in patients with melanoma—a huge relief for those affected Fertilitätserhalt beim Melanom – eine große Entlastung der Betroffenen (2023) Berking C, Hassel JC, Livingstone E Journal article CHRONIC TENOSYNOVITIS IS ASSOCIATED WITH LOSS OF GRIP STRENGTH IN PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS (OP0069) (2023) Bayat S, Coppers B, Kleyer A, Godonou ET, Valor L, Simon D, Fagni F, et al. Journal article Poor Adherence to Self-Applied Topical Drug Treatment Is a Common Source of Low Lesion Clearance in Patients with Actinic Keratosis—A Cross-Sectional Study (2023) Koch E, Steeb T, Bender-Säbelkampf S, Busch D, Feustel J, Kaufmann M, Maronna A, et al. Journal article Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy (2023) Reimann H, Kremer A, Blumenberg V, Schmidt K, Aigner M, Jacobs B, Eisenhauer N, et al. Journal article, Letter